Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, dal 1982 In collaborazione con l'Associazione Culturale Pediatri

Farmaci biologici

5 articoli — 2007-2026

0*18 Buongiorno futuro
Accesso libero
La cura diventa più mirata

2026/118 — pag. 2-3

0*18 Pillole
Accesso libero
I biologici in Reumatologia… cosa deve sapere il Pediatra

2024/110 — pag. 8-9

RI Farmacoriflessioni
Il dupilumab nell’esofagite eosinofila: una nuova frontiera?

Mainetti M, Troisi A, Turlà G, Fontijn S, Rametta G, Buzzi A, Mussetto A, Marchetti F.

2022/9 — pag. 583-587 — DOI

Eosinophilic oesophagitis (EoE) is a chronic, immune-mediated or antigen-mediated oe-sophageal disease. Therapeutic first-line options currently available for EoE are elimina-tion diets, proton pump inhibitors (PPIs) and steroids. The ultimate goal o...

RI Aggiornamento
Artrite idiopatica giovanile

L. Lepore, S. Pastore, A. Taddio

2020/6 — pag. 357-364

Juvenile idiopathic arthritis is the most frequent rheumatic disease in childhood. Its diagnosis is still clinical and recently new classification criteria have been proposed. Over the past twenty years, there have been significant improvement in u...

RI Farmacoriflessioni
I farmaci delle malattie infiammatorie croniche: dall’empirismo alla medicina molecolare

Giulia Gortani, Erica Valencic, Alberto Tommasini, Loredana Lepore

2007/6 — pag. 381-385

Chronic inflammatory diseases still represent a very dramatic problem in pediatric age. Therapeutic strategies are improving very quickly, but a complete control of disease progression is still a challenge. In a series of articles we try to address a...